PortfoliosLab logoPortfoliosLab logo
ISIN
US0231112063
CUSIP
023111206
IPO Date
Apr 1, 1993

Highlights

Market Cap
$307.76M
Enterprise Value
$182.28M
EPS (TTM)
-$0.12
Total Revenue (TTM)
$185.17M
Gross Profit (TTM)
$113.51M
EBITDA (TTM)
-$8.44M
Year Range
$12.96 - $20.90
Target Price
$2.17
ROA (TTM)
-5.21%
ROE (TTM)
-7.48%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

AMRN Performance Chart

Amarin Corporation plc (AMRN) is up 6.6% since the beginning of the year. At $15 per share, AMRN is trading 28.8% below its 52-week high of $21. Investors who bought $1,000 worth of AMRN shares 5 years ago would now be looking at an investment worth $164.


Loading charts...

S&P 500 Index

Returns By Period

Amarin Corporation plc (AMRN) has returned 6.63% so far this year and -12.11% over the past 12 months. Over the last ten years, AMRN has returned -10.36% per year, falling short of the S&P 500 Index benchmark, which averaged 13.41% annually.


Amarin Corporation plc

1D
-1.59%
1M
-2.36%
6M
-5.94%
YTD
6.63%
1Y
-12.11%
3Y*
-14.97%
5Y*
-30.32%
10Y*
-10.36%

Benchmark (S&P 500 Index)

1D
0.42%
1M
1.94%
6M
8.74%
YTD
10.66%
1Y
21.02%
3Y*
19.50%
5Y*
11.63%
10Y*
13.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMRN Monthly Returns History

Based on dividend-adjusted daily data since Apr 5, 1993, AMRN's average daily return is +0.13%, while the average monthly return is +2.59%. At this rate, an investment would double in approximately 2.3 years.

Historically, 43% of months were positive and 57% were negative. The best month was Sep 2018 with a return of +414.9%, while the worst month was Jun 1998 at -75.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, AMRN closed higher 42% of trading days. The best single day was Sep 24, 2018 with a return of +314.7%, while the worst single day was Apr 25, 2007 at -79.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.92%-7.51%4.78%-3.67%4.02%10.01%-6.65%6.63%
202518.85%-5.99%-17.31%20.06%7.71%39.95%-10.48%3.58%8.91%-0.55%-1.96%-12.62%43.87%
202429.89%-5.31%-16.75%3.38%-6.07%-20.46%-0.87%-8.28%0.22%-7.53%-12.02%-4.90%-44.25%
202353.72%9.14%-26.11%-10.00%-13.33%1.71%0.84%-12.50%-12.38%-24.34%12.34%11.25%-28.10%
20227.42%-8.56%-0.60%-18.24%-46.10%2.76%-10.74%-11.28%-7.63%12.84%-6.50%5.22%-64.09%
202153.37%-10.13%-7.86%-18.04%-10.81%-3.52%-5.48%31.40%-6.25%-6.47%-24.53%-6.39%-31.08%

Benchmark Metrics

Amarin Corporation plc has an annualized alpha of 28.50%, beta of 0.63, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since April 05, 1993.

  • This stock participated in 149.76% of S&P 500 Index downside but only 27.90% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.63 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
28.50%
Beta
0.63
0.01
Upside Capture
27.90%
Downside Capture
149.76%

Return for Risk

Risk / Return Rank

AMRN ranks 31 for risk / return — below 31% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


AMRN Risk / Return Rank: 3131
Overall Rank
AMRN Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
AMRN Sortino Ratio Rank: 3030
Sortino Ratio Rank
AMRN Omega Ratio Rank: 3030
Omega Ratio Rank
AMRN Calmar Ratio Rank: 3030
Calmar Ratio Rank
AMRN Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Amarin Corporation plc (AMRN) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMRNBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.97

Sortino ratioReturn per unit of downside risk

-2.46

Omega ratioGain probability vs. loss probability

0.98

1.30

-0.32

Calmar ratioReturn relative to maximum drawdown

-0.42

2.28

-2.70

Martin ratioReturn relative to average drawdown

-0.63

9.88

-10.52

Dividends

Dividend History


Amarin Corporation plc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Amarin Corporation plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Amarin Corporation plc was 99.97%, occurring on Mar 12, 2025. The portfolio has not yet recovered.

The current Amarin Corporation plc drawdown is 99.95%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-99.97%Mar 2025
31y 8mo
33y 7dJul 1993 - now
1993 correction1993
-12.77%Jun 1993
1d15d
16dJun 1993 - Jun 1993
1993 pullback1993
-7.89%May 1993
8d2d
10dMay 1993 - May 1993
1993 pullback1993
-7.69%Apr 1993
0s6d
6dApr 1993 - Apr 1993
1993 pullback1993
-4.17%Jun 1993
0s2d
2dJun 1993 - Jul 1993

Drawdown Indicators


AMRNBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.97%

-56.78%

-43.19%

Max Drawdown (1Y)

Largest decline over 1 year

-33.33%

-9.10%

-24.23%

Max Drawdown (3Y)

Largest decline over 3 years

-72.02%

-18.90%

-53.12%

Max Drawdown (5Y)

Largest decline over 5 years

-93.15%

-25.43%

-67.72%

Max Drawdown (10Y)

Largest decline over 10 years

-98.34%

-33.92%

-64.42%

Current Drawdown

Current decline from peak

-99.95%

-0.45%

-99.50%

Average Drawdown

Average peak-to-trough decline

-90.42%

-10.71%

-79.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.49%

2.09%

+20.40%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Amarin Corporation plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Amarin Corporation plc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AMRN relative to other companies in the Biotechnology industry. Currently, AMRN has a P/S ratio of 22.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AMRN in comparison with other companies in the Biotechnology industry. Currently, AMRN has a P/B value of 13.9. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with AMRN

Add Amarin Corporation plc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with AMRN